LGR5 and colorectal cancer: Mutations that augment Wnt ligand activity, e.g., in the LGR5 ligand RSPO, are mutually exclusive to APC mutations, illustrating two alternative pathways for oncogenic Wnt signaling in colorectal cancer (109).